BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hong KS, Kim YK, Bae HJ, Nam HS, Kwon SU, Bang OY, Cha JK, Yoon BW, Rha JH, Lee BC, Park JM, Park MS, Lee J, Choi JC, Kim DE, Lee KB, Park TH, Lee JS, Kim SE, Lee J. Quality of Anticoagulation with Warfarin in Korean Patients with Atrial Fibrillation and Prior Stroke: A Multicenter Retrospective Observational Study. J Clin Neurol 2017;13:273-80. [PMID: 28748679 DOI: 10.3988/jcn.2017.13.3.273] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Kim JY, Kim S, Myong J, Kim YR, Kim T, Kim J, Jang S, Oh Y, Lee MY, Rho T. Outcomes of Direct Oral Anticoagulants in Patients With Mitral Stenosis. Journal of the American College of Cardiology 2019;73:1123-31. [DOI: 10.1016/j.jacc.2018.12.047] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 10.3] [Reference Citation Analysis]
2 Steffel J, Eikelboom JW. Stroke prevention in AF: Of Asians and non-Asians. European Heart Journal 2019;40:1528-30. [DOI: 10.1093/eurheartj/ehy776] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Jung H, Yang P, Jang E, Yu HT, Kim T, Uhm J, Kim J, Pak H, Lee M, Joung B, Lip GY. Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation With Hypertrophic Cardiomyopathy. Chest 2019;155:354-63. [DOI: 10.1016/j.chest.2018.11.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
4 Lee S, Choi E, Kwon S, Jung J, Han K, Cha M, Oh S, Lip GY. Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use. Circ: Cardiovascular Quality and Outcomes 2020;13. [DOI: 10.1161/circoutcomes.119.005894] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Havers-borgersen E, Butt JH, Vinding NE, Torp-pedersen C, Gislason G, Køber L, Fosbøl EL. Time in therapeutic range and risk of thromboembolism and bleeding in patients with a mechanical heart valve prosthesis. The Journal of Thoracic and Cardiovascular Surgery 2020;159:74-83.e4. [DOI: 10.1016/j.jtcvs.2019.02.061] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Kwon S, Lee SR, Choi EK, Lee E, Jung JH, Han KD, Cha MJ, Oh S, Lip GYH. Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding. Stroke 2021;52:511-20. [PMID: 33412904 DOI: 10.1161/STROKEAHA.120.030761] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Kim JY, Kim SH, Myong JP, Choi Y, Hwang YM, Kim TS, Kim JH, Jang SW, Oh YS, Lee MY. Ten-year trends in the incidence, treatment and outcomes of patients with mitral stenosis in Korea. Heart 2020;106:746-50. [PMID: 32029525 DOI: 10.1136/heartjnl-2019-315883] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chao TF, Hong KS, Lee BC, De Caterina R, Kirchhof P, Reimitz PE, Chen C, Unverdorben M, Wang CC. Factors associated with the dosing of edoxaban for stroke prevention in patients with atrial fibrillation from South Korea and Taiwan: 1-year data from the Global ETNA-AF Program. J Chin Med Assoc 2021;84:485-90. [PMID: 33742992 DOI: 10.1097/JCMA.0000000000000516] [Reference Citation Analysis]
9 Giugliano RP, O’gara PT. DOACs in Patients With Mitral Stenosis and Atrial Fibrillation. Journal of the American College of Cardiology 2019;73:1132-4. [DOI: 10.1016/j.jacc.2018.12.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Qiu S, Wang N, Zhang C, Gu ZC, Qian Y. Anticoagulation Quality of Warfarin and the Role of Physician-Pharmacist Collaborative Clinics in the Treatment of Patients Receiving Warfarin: A Retrospective, Observational, Single-Center Study. Front Pharmacol 2020;11:605353. [PMID: 33519468 DOI: 10.3389/fphar.2020.605353] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Lee SR, Choi EK, Park CS, Han KD, Jung JH, Oh S, Lip GYH. Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight. J Am Coll Cardiol 2019;73:919-31. [PMID: 30819360 DOI: 10.1016/j.jacc.2018.11.051] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 20.5] [Reference Citation Analysis]
12 Wang N, Qiu S, Yang Y, Zhang C, Gu ZC, Qian Y. Physician-Pharmacist Collaborative Clinic Model to Improve Anticoagulation Quality in Atrial Fibrillation Patients Receiving Warfarin: An Analysis of Time in Therapeutic Range and a Nomogram Development. Front Pharmacol 2021;12:673302. [PMID: 34177585 DOI: 10.3389/fphar.2021.673302] [Reference Citation Analysis]
13 Lee SL, Ong TJ, Mazlan-Kepli W, Mageswaran A, Tan KH, Abd-Malek AM, Cronshaw R. Patients’ time in therapeutic range on warfarin among atrial fibrillation patients in Warfarin Medication Therapy Adherence Clinic. World J Cardiol 2021; 13(9): 483-492 [PMID: 34621493 DOI: 10.4330/wjc.v13.i9.483] [Reference Citation Analysis]
14 Park J, Lee SR, Choi EK, Kwon S, Jung JH, Han KD, Cha MJ, Ko SB, Oh S, Lip GYH. Effectiveness and Safety of Direct Oral Anticoagulant for Secondary Prevention in Asians with Atrial Fibrillation. J Clin Med 2019;8:E2228. [PMID: 31861095 DOI: 10.3390/jcm8122228] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
15 Kim SM, Jeon ET, Jung JM, Lee JS. Real-world oral anticoagulants for Asian patients with non-valvular atrial fibrillation: A PRISMA-compliant article. Medicine (Baltimore) 2021;100:e26883. [PMID: 34397907 DOI: 10.1097/MD.0000000000026883] [Reference Citation Analysis]
16 Li YG, Lee SR, Choi EK, Lip GY. Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients. Korean Circ J. 2018;48:665-684. [PMID: 30073805 DOI: 10.4070/kcj.2018.0190] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
17 Cho MS, Yun JE, Park JJ, Kim YJ, Lee J, Kim H, Park DW, Nam GB. Outcomes After Use of Standard- and Low-Dose Non-Vitamin K Oral Anticoagulants in Asian Patients With Atrial Fibrillation. Stroke. 2018;STROKEAHA118023093. [PMID: 30580716 DOI: 10.1161/strokeaha.118.023093] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
18 Kwon S, Lee S, Choi E, Choe W, Lee E, Jung J, Han K, Oh S, Lip GY. Non-vitamin K antagonist oral anticoagulants in very elderly east Asians with atrial fibrillation: A nationwide population-based study. American Heart Journal 2020;229:81-91. [DOI: 10.1016/j.ahj.2020.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Bang OY, On YK, Lee MY, Jang SW, Han S, Han S, Won MM, Park YJ, Lee JM, Choi HY, Kang S, Suh HS, Kim YH. The risk of stroke/systemic embolism and major bleeding in Asian patients with non-valvular atrial fibrillation treated with non-vitamin K oral anticoagulants compared to warfarin: Results from a real-world data analysis. PLoS One 2020;15:e0242922. [PMID: 33253294 DOI: 10.1371/journal.pone.0242922] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Viana CC, Praxedes MFDS, de Sousa WJFN, Bartolazzi F, Vianna MS, Silva JLPD, Martins MAP. Influence of sex-based differences on oral anticoagulation control in patients taking coumarin derivatives: a systematic review protocol. JBI Evidence Synthesis 2021;19:477-83. [DOI: 10.11124/jbies-20-00168] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Kim HM, Choi EK, Park CS, Cha MJ, Lee SY, Kwon JM, Oh S. Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in octogenarian patients with non-valvular atrial fibrillation. PLoS One 2019;14:e0211766. [PMID: 30845196 DOI: 10.1371/journal.pone.0211766] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]